137 related articles for article (PubMed ID: 36675457)
1. The SARS-COV-2 Seroprevalence among Oncology Patients.
Kgatle M; Das R; Lawal I; Boshomane T; Mokoala K; Gaspar C; Mbokazi L; Nkambule N; Gow V; Ndlovu H; Mzizi Y; Chalwe J; Diphofa J; Mokobodi D; Gxekwa N; Zongo L; Maphosa T; Vorster M; Bassa S; Venkatesan A; Khanyile R; Munga Y; Ebenhan T; Zeevaart JR; Sathekge M
J Clin Med; 2023 Jan; 12(2):. PubMed ID: 36675457
[TBL] [Abstract][Full Text] [Related]
2. Seroprevalence of SARS-CoV-2 infections among children visiting a hospital.
Wang R; Jin F; Cao S; Yuan H; Qu J; Zhang J; Li Y; Chen X; Song W; Xie Z
Pediatr Investig; 2020 Dec; 4(4):236-241. PubMed ID: 33376950
[TBL] [Abstract][Full Text] [Related]
3. The rate of SARS-CoV-2 among asymptomatic non-immunised low-risk parturient women between the two waves.
Al-Hussaini TK; EzzEldin AM; Shaaban OM; Abdel-Aleem MA; Kamal DT; Ibrahim MN
J Obstet Gynaecol; 2022 Aug; 42(6):1868-1873. PubMed ID: 35484953
[TBL] [Abstract][Full Text] [Related]
4. Seroprevalence of SARS-CoV-2-specific antibodies in cancer outpatients in Madrid (Spain): A single center, prospective, cohort study and a review of available data.
Cabezón-Gutiérrez L; Custodio-Cabello S; Palka-Kotlowska M; Oliveros-Acebes E; García-Navarro MJ; Khosravi-Shahi P
Cancer Treat Rev; 2020 Nov; 90():102102. PubMed ID: 32947121
[TBL] [Abstract][Full Text] [Related]
5. Epidemiology of SARS-CoV-2 Infection Evaluated by Immunochromatographic Rapid Testing for the Determination of IgM and IgG Against SARS-CoV-2 in a Cohort of Mask Wearing Workers in the Metal-Mechanical Sector in an Area With a High Incidence of COVID-19.
Esposito S; Neglia C; Affanni P; Colucci ME; Argentiero A; Veronesi L; Messina G; Deolmi M; Principi N;
Front Public Health; 2021; 9():628098. PubMed ID: 34249830
[No Abstract] [Full Text] [Related]
6. Seroprevalence and characteristics of Coronavirus Disease (COVID-19) in workers with non-specific disease symptoms.
Javed W; Abidi SHB; Baqar JB
BMC Infect Dis; 2022 May; 22(1):481. PubMed ID: 35596145
[TBL] [Abstract][Full Text] [Related]
7. High SARS-CoV-2 IgG/IGM seroprevalence in asymptomatic Congolese in Brazzaville, the Republic of Congo.
Batchi-Bouyou AL; Lobaloba Ingoba L; Ndounga M; Vouvoungui JC; Mfoutou Mapanguy CC; Boumpoutou KR; Ntoumi F
Int J Infect Dis; 2021 May; 106():3-7. PubMed ID: 33370565
[TBL] [Abstract][Full Text] [Related]
8. The prevalence of SARS-CoV-2 antibodies in triage-negative patients and staff of a fertility setting from lockdown release throughout 2020.
Manolea C; Capitanescu A; Borș R; Rugescu I; Bechir M; Mehedintu C; Varlas V
Hum Reprod Open; 2021; 2021(3):hoab028. PubMed ID: 34322605
[TBL] [Abstract][Full Text] [Related]
9. Retrospective analysis of seroprevalence in a cohort of university students of Rome (Italy) between September 2020 and July 2021.
Ulivieri A; Morgante A; Magi F; Salehi LB; Lavra L
Epidemiol Prev; 2022; 46(5-6):367-375. PubMed ID: 36628641
[TBL] [Abstract][Full Text] [Related]
10. Seroprevalence of anti-SARS-CoV-2 IgG Antibodies in the Staff of a Public School System in the Midwestern United States.
Lopez L; Nguyen T; Weber G; Kleimola K; Bereda M; Liu Y; Accorsi EK; Skates SJ; Santa Maria JP; Smith KR; Kalinich M
medRxiv; 2020 Oct; ():. PubMed ID: 33140066
[TBL] [Abstract][Full Text] [Related]
11. [Seroprevalence of anti-SARS-CoV-2 IgG/IgM antibodies in Borgosesia (Piedmont Region, Northern Italy) population: a surveillance strategy in post-lockdown period?].
Alessi D; Borré S; Barale A; Isabella A; Milano F; Rossi MA; Silano V; Piu N; Cena T; Faggiano F;
Epidemiol Prev; 2020; 44(5-6 Suppl 2):200-206. PubMed ID: 33412811
[TBL] [Abstract][Full Text] [Related]
12. Longitudinal Monitoring of SARS-CoV-2 IgM and IgG Seropositivity to Detect COVID-19.
Suhandynata RT; Hoffman MA; Kelner MJ; McLawhon RW; Reed SL; Fitzgerald RL
J Appl Lab Med; 2020 Sep; 5(5):908-920. PubMed ID: 32428207
[TBL] [Abstract][Full Text] [Related]
13. Prevalence of SARS -CoV-2 IgG/IgM antibodies among patients in Zakho City, Kurdistan, Iraq.
Saeed AY; Assafi MS; Othman HE; Shukri HM
J Infect Dev Ctries; 2022 Jul; 16(7):1126-1130. PubMed ID: 35905016
[TBL] [Abstract][Full Text] [Related]
14. Seroprevalence of SARS-CoV-2-specific anti-spike IgM, IgG, and anti-nucleocapsid IgG antibodies during the second wave of the pandemic: A population-based cross-sectional survey across Kashmir, India.
Lone KS; Khan SMS; Qurieshi MA; Majid S; Pandit MI; Haq I; Ahmad J; Bhat AA; Bashir K; Bilquees S; Fazili AB; Hassan M; Jan Y; Kaul RR; Khan ZA; Mushtaq B; Nazir F; Qureshi UA; Raja MW; Rasool M; Asma A; Bhat AA; Chowdri IN; Ismail S; Jeelani A; Kawoosa MF; Khan MA; Khan MS; Kousar R; Lone AA; Nabi S; Qazi TB; Rather RH; Sabah I; Sumji IA
Front Public Health; 2022; 10():967447. PubMed ID: 36276377
[TBL] [Abstract][Full Text] [Related]
15. Rapid and Laboratory SARS-CoV-2 Antibody Testing in High-Risk Hospital Associated Cohorts of Unknown COVID-19 Exposure, a Validation and Epidemiological Study After the First Wave of the Pandemic.
O'Kelly B; McLaughlin R; O'Doherty R; Carroll H; Murray R; Dilworth R; Corkery L; Cotter AG; McGinty T; Muldoon EG; Cullen W; Avramovic G; Sheehan G; Sadlier D; Higgins M; O'Gorman P; Doran P; Inzitari R; Holden S; O'Meara Y; Ennis S; Lambert JS
Front Med (Lausanne); 2021; 8():642318. PubMed ID: 34513853
[No Abstract] [Full Text] [Related]
16. COVID-19 seroprevalence and clinical picture in Swedish pediatric oncology and hematology patients.
Sundberg E; Hoffman T; Nilsson A; Pahnke S; Enblad G; Kolstad L; Rönnberg B; Lundkvist Å; Torkki M; Zhou O; Anderson J; Harila-Saari A; Palle J
Pediatr Blood Cancer; 2022 Oct; 69(10):e29773. PubMed ID: 35615775
[TBL] [Abstract][Full Text] [Related]
17. Seroprevalence of IgM and IgG Against SARS-CoV-2 after Two Doses of Pfizer-BioNTech COVID-19 Vaccine in Women with Breast Cancer.
Almehmadi M; Salih MM; Shafie A; Alsharif A; Alsiwiehr N; El-Askary A; Alzahrani K; Al-Hazmi A; Aljuaid A; Abdulazziz O; Almalki AA; Allahyani M; Eed E; Alharbi AM; Halawi M; Allam HH; Abutawil H; Alosimi E; Gharib AF
Clin Lab; 2022 Nov; 68(11):. PubMed ID: 36378000
[TBL] [Abstract][Full Text] [Related]
18. Severe acute respiratory syndrome coronavirus 2 seroprevalence survey among 10,256 workers in Kuwait.
Altawalah H; Alfouzan W; Dhar R; Alali W; Bastaki H; Al-Fadalah T; Al-Ghimlas F; Rabaan AA; Ezzikouri S
J Clin Virol Plus; 2021 Jun; 1(1):100017. PubMed ID: 35262005
[TBL] [Abstract][Full Text] [Related]
19. Enzyme-Linked Immunosorbent Assay for the Detection of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) IgM/IgA and IgG Antibodies Among Healthcare Workers.
Alharbi SA; Almutairi AZ; Jan AA; Alkhalify AM
Cureus; 2020 Sep; 12(9):e10285. PubMed ID: 33047077
[TBL] [Abstract][Full Text] [Related]
20. Seroprevalence of SARS-CoV-2 immunoglobulin G in HIV-positive and HIV-negative individuals in KwaZulu-Natal, South Africa.
Francois KA; Msomi N; Govender K; Gounder L; Moodley P; Parboosing R; Chetty I; Xaba L; Khan A
Afr J Lab Med; 2023; 12(1):2065. PubMed ID: 37434993
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
